Phase 3 ASPEN Trial Testing Brensocatib Now Recruiting; First Patient Dosed
News
The first participant has been dosed in ASPEN, a Phase 3 trial — now recruiting patients — that is evaluating the investigational medication brensocatib in people with non-cystic fibrosis (CF) ... Read more